- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips Enters North American Mammo Market with New System
Given concerns about radiation dose and a call for more comfortable machines, officials at Philips saw an opportunity for a new product in the North American mammography market. Last week Philips introduced their MicroDose Mammography system, which officials said provides a lower dose, less stressful scan.
Given concerns about radiation dose and a call for more comfortable machines, officials at Philips saw an opportunity for a new product in the North American mammography market. Last week Philips introduced their MicroDose Mammography system, which officials said provides a lower dose, less stressful scan.
“The U.S. is in the process of turning over the generation one machines to a purchase cycle, so we believe this is the perfect product” for the market, said Pam Benkert, general manager, women’s healthcare for Philips Healthcare. “We wanted a differentiated offering.”
MicroDose is the only FDA-cleared mammography system to use X-ray photon counting technology. The detector captures almost every photon that travels from the source to the breast to the detector, Benkert explained. There’s very little scatter, which allows for an up to 50 percent dose reduction, she said.
The machine also has curved support and a warm position surface, intended to make it more comfortable for the patient, she said.
The product, she said, is “uniquely suited to the population” in North America.
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.
